Total buying$30.0M2 buys
ASPE
Aspen Neuroscience, Inc.
Unclassified
Insider activity for last month from 10/05 to 11/05.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$00 sells
Net open-market+$30.0MBuying minus selling
Active insiders3Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Nov 04, 2026
Open-market transaction mix · 2 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Oct 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
| Nov 2026 | 2 | 0 | 0 | $30.0M | $0 | $30.0M |
Distinct insiders active
Reporting-owner CIKs by month · peak Nov 2026 (3)Oct 2026Nov 2026
Largest insider activity
By absolute net disclosed value · current transaction page- TA—
- OL—
ASPE transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period22transactionstxns
- C · Code C · dominant20 · 91%
- P · Open-market buys2 · 9%
Activity by reported role
A joint filing can contribute to multiple rolesDirector22
Reported Holdings After
Separated by insider, security, and ownership type
Orbimed Advisors LLCCommon Stock · Indirect · See footnotes
3,589,132Nov 02, 2026
OrbiMed Capital GP VII LLCCommon Stock · Indirect · See footnotes
3,589,132Nov 02, 2026
Thompson Peter A.Common Stock · Indirect · See footnotes
3,589,132Nov 02, 2026
Orbimed Advisors LLCSeries Seed-2 Convertible Preferred Stock · Indirect · See footnotes
0Nov 02, 2026
Orbimed Advisors LLCSeries A-1 Convertible Preferred Stock · Indirect · See footnotes
0Nov 02, 2026
Orbimed Advisors LLCSeries A-2 Convertible Preferred Stock · Indirect · See footnotes
0Nov 02, 2026
Orbimed Advisors LLCSeries B Convertible Preferred Stock · Indirect · See footnotes
0Nov 02, 2026
Orbimed Advisors LLCSeries C Convertible Preferred Stock · Indirect · See footnotes
0Nov 02, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redOct 05 → Nov 05
LessMore
Aspen Neuroscience, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Aspen Neuroscience, Inc.?
Thompson Peter A., ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC.
When was the latest reported open-market purchase?
Thompson Peter A. reported a buy on Nov 02, 2026 valued at $15.0M. Read the SEC filing.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
Net open-market buying in the selected period was $30,000,000.00. This describes filed transactions, not a bullish rating.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.